Wednesday Bubble: Scentuelle seduction
[youtube=http://www.youtube.com/watch?v=Y1PVmANeyAg]
About a week ago, a friend of mine sent me a link to Scentuelle™, an “aroma” patch that uses a woman’s sense of smell to enhance sexual response. According to the website, Scentuelle targets smell receptors at the back of nose closest to the brain “with a sensuous blend of aromas” that mimic dopamine, a naturally-occurring chemical associated with pleasure. Dopamine has been directly linked with sexual activity, food and other pleasurable experiences. Manufacturers of Scentuelle claim that because it acts like dopamine, it increases happiness and by default, arousal. Evidently, Scentuelle’s effect is cumulative and reaches optimal level after three weeks.
Aromatherapy is not a new concept and I’m willing, as with Zestra, to give Scentuelle a go. In fact, I’ve registered to participate in a user study to check it out.
I’d like to believe the hype. But who knows? Zestra turned out to be a major dud although the Company’s president recently sent me an email with a link to a New York Times piece that “proves” otherwise. Personally, the smell and feel of Zestra alone was enough to turn off three women who tested it for this blog, all within a short period of time, but if it works for some, hey, good for them.
I’ll make a formal announcement when the study commences and I start testing it out. Hey, why not? I’m all for a bit of Scentuelle seduction!
Happy Wednesday!
Read MoreHRT – the cat’s outta da bag
Does Wyeth’s hormone replacement therapy agent Prempro cause breast cancer? Yes, according to a jury, who recently awarded Connie Barton $75 million in punitive damages.
According to a statement quoted in a New York Times expose, a spokesperson for the pharma giant Pfizer (which recently merged with Wyeth) emphatically claims that Preempro is “a safe, federally approved drug that did not cause [the woman’s] breast cancer.”And yet, Preempro is the very same drug caused the abrupt halt of the Women’s Health Initiative trial when it was found to double the risk for breast cancer as well as increase the risk for heart attack, stroke and blood clots. Moreover, later analysis of the Women’s Health Initiative data showed that hormones also increased the risk for dementia in a subset of women. Still, the company plans to fight every Preempro award, maintaining that it has acted responsibly and has posted every warning in line with FDA guidelines.
So what do you do when a drug has known dangers, a warped risk-benefit ratio and is still widely marketed? As I’ve written time and again on this blog, many in the medical profession continue to believe in HRT and prescribe it regularly, not for “good health” or to slow the aging process but to control the more troublesome symptoms of menopause (e.g. hot flashes, night sweats and vaginal dryness). And thousands of women continue to toe the party line, believing that that hormone replacement is essential to easing the aging journey (as the article’s author so aptly points out, the term “replacement” implies that it is something that is needed).
Interestingly the article maps out strategies that have been used to influence physicians, professional societies and women so as to deflect attention away from cancer concerns towards the positive, risk-preventive properties of hormone therapy. And while this piece makes me want to jump on my soapbox, I won’t attempt to dissect it further because it’s one of the most thorough and well-researched articles I’ve read in some time. The only thing I will leave you with is that Wyeth’s actions are a true reflection of everything that’s wrong with the modern view of menopause, from menopause as a disease to waning estrogen as a symbol of all that is unattractive about an aging woman.
Rather than “rebalancing” our bodies through modern medicine, shouldn’t we be focusing on what we can do to balance the transition as we move through our lives by focusing on our relationships, our activity levels, our psyches, our connections and our diets? You can’t fix something when it’s not broken. And the only thing that appears to be broken here is the hype.
Yes, the HRT cat’s outta da bag. What do you think?
Read MoreMove over, red clover
There’s interesting news on the red clover front.
Although red clover may have questionable value when it comes to hot flashes (the verdict is still out with regards to whether or not it is effective) researchers are now saying that this isoflavone may be useful for reducing depression and anxiety in menopausal women.
In a study published in the online edition of Maturitas journal, over 200 menopausal women received 2-80 mg red clover capsules or sugar tablet for 90 days, took a break, and then were assigned the opposite medication for another 90 days. The researchers measured anxiety and depression at the study’s start, at 90 days and at the study’s completion.
Taking red clover reduced total anxiety and depression by as much as 77%, compared to declines following placebo (which overall, declined about 21%). This decline could likely be attributed to what is known as the placebo effect, in which some an improvement is perceived to be real.
About red clover
Red clover is a perennial whose flowers have long been dried and used therapeutically in complementary medicine. It’s a known source of calcium, chromium, magnesium, niacin, phosphorus, potassium, thiamine, and vitamin C. Researchers have studied its utility in heart disease, cancer, osteoporosis and of course menopause. Herbalists also use red clover topically for eczema, psoriasis and other rashes. Although most people tolerate red clover very well, it has been associated with headache, nausea and rash. Animals who graze on large amounts of red clover have also become infertile. It can also interfere with certain drugs that are metabolized by the liver and can enhance the effects of estrogens, birth control and blood thinners.
Should you take red clover for anxiety and depression? The verdict is early but it is looking promising. As always, peak to a licensed, knowledgeable practitioner before using red clover with any regularity for any condition.
Read MoreWednesday Bubble: there ain’t no men in menopause, part two
This saddens me greatly but maybe it’s true after all. It is really all about us.
But is it?
In early November, I put out a call for male contributors, hoping to find some male voices to fill the obvious void on this blog and lend their perspectives — not just on menopause — but on midlife. I was hoping to find men of all ages who could share their experiences with crazy moms going through hormonal mood swings, partners flashing night and day and in general, this time of life means for the other half of the equation, i.e. men. Let’s face it, we’re not going to come to the table if we don’t understand the issues, right? However, thus far, I’ve had only one courageous man willing to share his POV and another contact me to discuss possibly topics. And the slots remain empty.
Recently, I had a back channel conversation on Twitter with a young male blogger about men’s general lack of interest in discussing the female anatomy or so-called “female problems.” His take? That men are generally apathetic and unaware when it comes to this stuff. And while I know plenty of men, sensitive or not, who would welcome an opportunity to speak their peace in their relationships, I can’t seem to find any takers for this challenge. Perhaps it’s the term “menopause” in the tagline that causes men to approach trepedatiously.
I thought I’d try again. Three’s a charm, right? I’m not looking for just a discussion on menopause, but a discussion on what it’s like to deal with a woman going through such a drastic transition in her life. I’d eve love posts on what you might imagine it might be like, or how your female partners can change the way that they communicate with you now so that some of the issues that might arise later can be averted or avoided altogether. Anything and everything.
So are there men in menopause? Send me your ideas. OR comment and let me know WHY you don’t want to post.
I need you. I really really do!
Read MoreArchives
Tags
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.